"Our data ... bolster the case for the use of aspirin and (non-steroidal anti-inflammatory drugs) as chemopreventive agents against breast cancer," the researchers wrote.
Aspirin was first developed in Germany around 1897 when chemist Felix Hoffman sought a remedy for his father's crippling arthritis. It is extracted from willow bark. Now, more than 100 years later, it appears aspirin's ultimate calling may be disease "prevention", not just "pain treatment".
Some Other Good and Bad Findings
In November 2002, aspirin was shown to conclusively reduces the risk of a first heart attack by 32%, according to a report by researchers at Mount Sinai Medical Center & Miami Heart Institute. The findings were presented at the American Heart Association's Scientific Sessions in Chicago.
However, in October, 2003, a study of 88,000 nurses, conducted by Harvard Medical School and Brigham and Women's Hospital in Boston, found that subjects who took two or more aspirins a week for 20 years or more had a 58 % higher risk of pancreatic cancer. Like all early claims, the data has yet to be fully corroborated by other labs.
Don’t Forget The Mammograms And Self-Exams
Although the connection between aspirin and breast cancer mitigation is encouraging, the data has yet to be corroborated. Women should continue with their regular early detection habits.
Doctors say to try to get in the habit of doing a breast self-examination once a month to familiarize yourself with how your breasts normally look and feel. Examine yourself several days after your period ends, when your breasts are least likely to be swollen and tender. If you are no longer having periods, choose a day that's easy to remember, such as the first or last day of the month.
It is recommended a mammogram be done yearly for females over the age of 40.
Source: United Press International